▶ 調査レポート

API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場2020-2030:製品別(コンドロイチン硫酸、ヒアルロン酸[天然および合成]、パンクレアチン)、種類別、エンドユーザー別

• 英文タイトル:API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market (Product: Chondroitin Sulfate, Hyaluronic Acid [Natural and Synthetic], and Pancreatin; Type: Pellets, Powder, and Others; and End User: Pharmaceutical Companies, Biotechnology Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Transparency Market Researchが調査・発行した産業分析レポートです。API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場2020-2030:製品別(コンドロイチン硫酸、ヒアルロン酸[天然および合成]、パンクレアチン)、種類別、エンドユーザー別 / API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market (Product: Chondroitin Sulfate, Hyaluronic Acid [Natural and Synthetic], and Pancreatin; Type: Pellets, Powder, and Others; and End User: Pharmaceutical Companies, Biotechnology Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / D0SP21036資料のイメージです。• レポートコード:D0SP21036
• 出版社/出版日:Transparency Market Research / 2020年7月31日
• レポート形態:英文、PDF、224ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥660,630 (USD5,795)▷ お問い合わせ
  Multi User¥1,002,630 (USD8,795)▷ お問い合わせ
  Corporate License¥1,344,630 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(コンドロイチン硫酸、ヒアルロン酸[天然および合成]、パンクレアチン)分析、種類別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場:製品別(コンドロイチン硫酸、ヒアルロン酸[天然および合成]、パンクレアチン)
・API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場:種類別
・API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場:エンドユーザー別
・API(コンドロイチン硫酸・ヒアルロン酸・パンクレアチン)の世界市場:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market – Scope of the Report

TMR’s report on the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue and volume of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market for the forecast period.

The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market.

The report delves into the competition landscape of the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market. Key players operating in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market that have been profiled in this report.

Key Questions Answered in API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Report

What is the sales/revenue generated by each product, type, and end user segment of the API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market across all regions during the forecast period?
What are the opportunities in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is likely to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2019?
API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market – Research Objectives and Research Approach

The comprehensive report on the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, key industrial developments in terms of mergers, acquisitions, strategic partnerships, key investments, regulatory scenario, pricing analysis, value chain analysis, technological advancements, key vendor & distributor analysis, and COVID-19 pandemic impact on the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) industry have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market in terms of product, type, end user, and region. Key segments under each criteria have been studied at length and the market share for each of them at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market

4. Market Overview

4.1. Introduction

4.1.1. Product Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

4.4.2. Market Volume/Unit Shipments Projections

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Price Comparison Analysis, 2019

5.1.1. By Product Type

5.2. Key Vendor and Distributor Analysis

5.3. Regulatory Scenario by Region/globally

5.4. Value Chain Analysis

5.5. Recent Developments in Technologies

5.6. COVID-19 Epidemics Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value & Volume Forecast, by Product, 2018–2030

6.3.1. Chondroitin Sulfate

6.3.2. Hyaluronic Acid

6.3.2.1. Natural

6.3.2.2. Synthetic

6.3.3. Pancreatin

6.4. Market Attractiveness Analysis, by Product

7. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Type, 2018–2030

7.3.1. Pellets

7.3.2. Powder

7.3.3. Others

7.4. Market Attractiveness Analysis, by Type

8. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by End-user, 2018–2030

8.3.1. Pharmaceutical Companies

8.3.2. Biotechnology Companies

8.3.3. Others

8.4. Market Attractiveness Analysis, by End-user

9. Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Market Value & Volume Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness Analysis, by Country/Region

10. North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Market Value & Volume Forecast, by Product, 2018–2030

10.2.1. Chondroitin Sulfate

10.2.2. Hyaluronic Acid

10.2.2.1. Natural

10.2.2.2. Synthetic

10.2.3. Pancreatin

10.3. Market Value Forecast, by Type, 2018–2030

10.3.1. Pellets

10.3.2. Powder

10.3.3. Others

10.4. Market Value Forecast, by End-user, 2018–2030

10.4.1. Pharmaceutical Companies

10.4.2. Biotechnology Companies

10.4.3. Others

10.5. Market Value Forecast, by Country, 2018–2030

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Type

10.6.3. By End-user

10.6.4. By Country

11. Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value & Volume Forecast, by Product, 2018–2030

11.2.1. Chondroitin Sulfate

11.2.2. Hyaluronic Acid

11.2.2.1. Natural

11.2.2.2. Synthetic

11.2.3. Pancreatin

11.3. Market Value Forecast, by Type, 2018–2030

11.3.1. Pellets

11.3.2. Powder

11.3.3. Others

11.4. Market Value Forecast, by End-user, 2018–2030

11.4.1. Pharmaceutical Companies

11.4.2. Biotechnology Companies

11.4.3. Others

11.5. Market Value Forecast, by Country/Sub-region, 2018–2030

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Type

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value & Volume Forecast, by Product, 2018–2030

12.2.1. Chondroitin Sulfate

12.2.2. Hyaluronic Acid

12.2.2.1. Natural

12.2.2.2. Synthetic

12.2.3. Pancreatin

12.3. Market Value Forecast, by Type, 2018–2030

12.3.1. Pellets

12.3.2. Powder

12.3.3. Others

12.4. Market Value Forecast, by End-user, 2018–2030

12.4.1. Pharmaceutical Companies

12.4.2. Biotechnology Companies

12.4.3. Others

12.5. Market Value Forecast, by Country/Sub-region, 2018–2030

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Type

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value & Volume Forecast, by Product, 2018–2030

13.2.1. Chondroitin Sulfate

13.2.2. Hyaluronic Acid

13.2.2.1. Natural

13.2.2.2. Synthetic

13.2.3. Pancreatin

13.3. Market Value Forecast, by Type, 2018–2030

13.3.1. Pellets

13.3.2. Powder

13.3.3. Others

13.4. Market Value Forecast, by End-user, 2018–2030

13.4.1. Pharmaceutical Companies

13.4.2. Biotechnology Companies

13.4.3. Others

13.5. Market Value Forecast, by Country/Sub-region, 2018–2030

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Type

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value & Volume Forecast, by Product, 2018–2030

14.2.1. Chondroitin Sulfate

14.2.2. Hyaluronic Acid

14.2.2.1. Natural

14.2.2.2. Synthetic

14.2.3. Pancreatin

14.3. Market Value Forecast, by Type, 2018–2030

14.3.1. Pellets

14.3.2. Powder

14.3.3. Others

14.4. Market Value Forecast, by End-user, 2018–2030

14.4.1. Pharmaceutical Companies

14.4.2. Biotechnology Companies

14.4.3. Others

14.5. Market Value Forecast, by Country/Sub-region, 2018–2030

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Type

14.6.3. By End-user

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Market Share/Position Analysis, by Company, 2019

15.3. Company Profiles

15.3.1. Summit Nutritionals International, Inc.

15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.1.2. Company Financials

15.3.1.3. Growth Strategies

15.3.1.4. SWOT Analysis

15.3.2. Sioux Pharm, Inc.

15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.2.2. Company Financials

15.3.2.3. Growth Strategies

15.3.2.4. SWOT Analysis

15.3.3. TSI Group Ltd.

15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.3.2. Company Financials

15.3.3.3. Growth Strategies

15.3.3.4. SWOT Analysis

15.3.4. Shandong Runxin Biotechnology Co., Ltd.

15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.4.2. Company Financials

15.3.4.3. Growth Strategies

15.3.4.4. SWOT Analysis

15.3.5. ZPD A/S

15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.5.2. Company Financials

15.3.5.3. Growth Strategies

15.3.5.4. SWOT Analysis

15.3.6. Pacific Rainbow International, Inc.

15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.6.2. Company Financials

15.3.6.3. Growth Strategies

15.3.6.4. SWOT Analysis

15.3.7. SEIKAGAKU CORPORATION

15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.7.2. Company Financials

15.3.7.3. Growth Strategies

15.3.7.4. SWOT Analysis

15.3.8. Synutra, Inc.

15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.8.2. Company Financials

15.3.8.3. Growth Strategies

15.3.8.4. SWOT Analysis

15.3.9. Bioiberica S.A.U.

15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.9.2. Company Financials

15.3.9.3. Growth Strategies

15.3.9.4. SWOT Analysis

15.3.10. Newgen Biotech USA Inc.

15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.10.2. Company Financials

15.3.10.3. Growth Strategies

15.3.10.4. SWOT Analysis

15.3.11. Nordmark Arrzneimittel GmbH & Co. KG

15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.11.2. Company Financials

15.3.11.3. Growth Strategies

15.3.11.4. SWOT Analysis

15.3.12. Qingdao WanTuMing Biological Products Co., Ltd.

15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

15.3.12.2. Company Financials

15.3.12.3. Growth Strategies

15.3.12.4. SWOT Analysis

List of Tables

Table 01: Key Vendor and Distributor Analysis

Table 02: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 03: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 04: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 05: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 06: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 07: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 08: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: Global API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Region, 2018–2030

Table 10: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 11: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 12: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 13: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 14: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 15: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 16: North America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 19: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 20: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 21: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 22: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 23: Europe API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 24: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 26: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 27: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 28: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 29: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 30: Asia Pacific API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 31: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 32: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 33: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 34: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 35: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 36: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 37: Latin America API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 38: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 39: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 40: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Product, 2018–2030

Table 41: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Hyaluronic Acid, 2018–2030

Table 42: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Volume (Tons) Forecast, by Hyaluronic Acid, 2018–2030

Table 43: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 44: Middle East & Africa API (Chondroitin Sulfate, Hyaluronic Acid and Pancreatin) Market Value (US$ Mn) Forecast, by End-user, 2018–2030